Cabio Biotech (Wuhan) Dividends and Buybacks
Dividend criteria checks 2/6
Cabio Biotech (Wuhan) is a dividend paying company with a current yield of 0.96% that is well covered by earnings.
Key information
1.0%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 1.2% |
| Future Dividend Yield | 0% |
| Dividend Growth | 7.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.200 |
| Payout ratio | 29% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 688089 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 688089 has only been paying a dividend for 4 years, and since then payments have fallen.
Dividend Yield vs Market
| Cabio Biotech (Wuhan) Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688089) | 1.0% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Chemicals) | 1.7% |
| Analyst forecast (688089) (up to 3 years) | 0% |
Notable Dividend: 688089's dividend (0.96%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 688089's dividend (0.96%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (29.5%), 688089's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 688089 is paying a dividend but the company has no free cash flows.